Advertisement
MED vs RGS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MED is a Buy and RGS is a Hold.
MED in upward trend: 10-day moving average broke above 50-day moving average on October 22, 2026
The 10-day moving average for MED crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on MED as a result. In 68 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for MED just turned positive on October 14, 2026. Looking at past instances where MED's MACD turned positive, the stock continued to rise in 35 of 58 cases over the following month. The odds of a continued upward trend are 60%.
MED moved above its 50-day moving average on October 26, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in 147 of 240 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 72 of 100 cases where MED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 49 cases where MED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
MED broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.713) is normal, around the industry mean (7.903). MED has a moderately low P/E Ratio (-5.378) as compared to the industry average of (10.602). Projected Growth (PEG Ratio) (0.230) is also within normal values, averaging (4.440). MED's Dividend Yield (0.527) is considerably higher than the industry average of (0.078). P/S Ratio (0.416) is also within normal values, averaging (1.645).
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
RGS sees MACD Histogram crosses below signal line
RGS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 14, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 38 instances where the indicator turned negative. In 34 of the 38 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 89%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for RGS moved out of overbought territory on October 01, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 21 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 39 of 46 cases where RGS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
RGS broke above its upper Bollinger Band on September 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on RGS as a result. In 67 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The 10-day moving average for RGS crossed bullishly above the 50-day moving average on September 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +0.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where RGS advanced for three days, in 200 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 109 of 148 cases where RGS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. RGS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 52 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.376) is normal, around the industry mean (7.903). P/E Ratio (10.551) is within average values for comparable stocks, (10.602). Projected Growth (PEG Ratio) (4.660) is also within normal values, averaging (4.440). Dividend Yield (0.165) settles around the average of (0.078) among similar stocks. P/S Ratio (0.359) is also within normal values, averaging (1.645).
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
MED | RGS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 36 | 60 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 3 Undervalued | 52 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 86 | |
PRICE GROWTH RATING 1..100 | 49 | 47 | |
P/E GROWTH RATING 1..100 | 97 | 1 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MED's Valuation (3) in the Specialty Stores industry is somewhat better than the same rating for RGS (52) in the Other Consumer Services industry. This means that MED’s stock grew somewhat faster than RGS’s over the last 12 months.
MED's Profit vs Risk Rating (100) in the Specialty Stores industry is in the same range as RGS (100) in the Other Consumer Services industry. This means that MED’s stock grew similarly to RGS’s over the last 12 months.
RGS's SMR Rating (86) in the Other Consumer Services industry is in the same range as MED (94) in the Specialty Stores industry. This means that RGS’s stock grew similarly to MED’s over the last 12 months.
RGS's Price Growth Rating (47) in the Other Consumer Services industry is in the same range as MED (49) in the Specialty Stores industry. This means that RGS’s stock grew similarly to MED’s over the last 12 months.
RGS's P/E Growth Rating (1) in the Other Consumer Services industry is significantly better than the same rating for MED (97) in the Specialty Stores industry. This means that RGS’s stock grew significantly faster than MED’s over the last 12 months.
| MED | RGS | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 84% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 72% | 1 day ago 77% |
| MACD ODDS (%) | 1 day ago 60% | 1 day ago 89% |
| TrendWeek ODDS (%) | 1 day ago 59% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 66% | 1 day ago 77% |
| Advances ODDS (%) | 1 day ago 61% | 8 days ago 82% |
| Declines ODDS (%) | 6 days ago 84% | 1 day ago 87% |
| BollingerBands ODDS (%) | 1 day ago 90% | 6 days ago 87% |
| Aroon ODDS (%) | 1 day ago 72% | 1 day ago 74% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MED’s FA Score shows that 1 FA rating(s) are green while RGS’s FA Score has 1 green FA rating(s).
- MED’s FA Score: 1 green, 4 red.
- RGS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MED’s TA Score shows that 6 TA indicator(s) are bullish while RGS’s TA Score has 4 bullish TA indicator(s).
- MED’s TA Score: 6 bullish, 3 bearish.
- RGS’s TA Score: 4 bullish, 5 bearish.
Price Growth
MED (@Personnel Services) experienced а +0.80% price change this week, while RGS (@Personnel Services) price change was -1.09% for the same time period.
The average weekly price growth across all stocks in the @Personnel Services industry was -2.94%. For the same industry, the average monthly price growth was -4.08%, and the average quarterly price growth was -11.27%.
Reported Earning Dates
MED is expected to report earnings on Feb 23, 2027.
RGS is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Personnel Services (-2.94% weekly)Personnel Services comprise companies that provide staffing and human resources management solutions for businesses. Each company might be involved in one or more types of recruitment or employee solutions such as permanent or temporary staffing, career consulting, outsourcing, administrative services and many more. Some personnel services companies cater to large businesses, while some specialize in providing services to small/medium-sized organizations. These specialized services potentially expedite the process of getting the ‘right’ candidates and/or training them to meet the requirements of a business process. Some of the companies also cover other critical areas like internal auditing for a company. Robert Half International Inc., ManpowerGroup Inc. and Insperity, Inc. are examples of companies in the personnel services industry.
Advertisement
MED and
Correlation & Price change
A.I.dvisor indicates that over the last year, MED has been loosely correlated with EXPE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MED jumps, then EXPE could also see price increases.
| Ticker / NAME | Correlation To MED | 1D Price Change % | ||
|---|---|---|---|---|
| MED | 100% | +0.48% | ||
| EXPE - MED | 36% Loosely correlated | -4.42% | ||
| TNL - MED | 23% Poorly correlated | -0.16% | ||
| SABR - MED | 21% Poorly correlated | N/A | ||
| NCLH - MED | 20% Poorly correlated | -2.90% | ||
| TRIP - MED | 20% Poorly correlated | N/A | ||
More | ||||
RGS and
Correlation & Price change
A.I.dvisor tells us that RGS and TRIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGS and TRIP's prices will move in lockstep.
| Ticker / NAME | Correlation To RGS | 1D Price Change % | ||
|---|---|---|---|---|
| RGS | 100% | -0.55% | ||
| TRIP - RGS | 28% Poorly correlated | N/A | ||
| BKNG - RGS | 27% Poorly correlated | +1.25% | ||
| RCL - RGS | 25% Poorly correlated | -2.46% | ||
| TNL - RGS | 23% Poorly correlated | -0.16% | ||
| CCL - RGS | 22% Poorly correlated | -2.83% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVGU | 24.18 | 1.33 | +5.83% |
| GraniteShares 2x Long AVGO Daily ETF (AVGU) | |||
| RNTY | 47.78 | N/A | +0.01% |
| Yieldmax Target 12 Real Estate Option Income ETF | |||
| GTOQ | 21.47 | N/A | N/A |
| Invesco High Yield Systematic Bond ETF (GTOQ) | |||
| DFJ | 110.16 | -0.72 | -0.65% |
| WisdomTree Japan SmallCap Dividend Fund (DFJ) | |||
| BSVO | 28.85 | -0.27 | -0.93% |
| EA Bridgeway Omni Small-Cap Value ETF (BSVO) | |||